title: Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.
authors.forename: Paolo
authors.initials: P
authors.lastname: Anderlini
authors.forename: Nancy
authors.initials: N
authors.lastname: Swanston
authors.forename: Ashif
authors.initials: A
authors.lastname: Rashid
authors.forename: Carlos
authors.initials: C
authors.lastname: Bueso-Ramos
authors.forename: Homer A
authors.initials: HA
authors.lastname: Macapinlac
authors.forename: Richard E
authors.initials: RE
authors.lastname: Champlin
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D001761:Bleomycin; D001853:Bone Marrow / Q000473:pathology; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology; D003606:Dacarbazine; D004317:Doxorubicin; D020350:Graft vs Tumor Effect; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D012867:Skin / Q000473:pathology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014747:Vinblastine
chemical_list: D007166:Immunosuppressive Agents; D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin